SHARON BENZENO - Chief Commercial Ofc Imm Med at Adaptive Biotechnologies Corp

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Commercial Ofc Imm Med
Issuer Symbol
ADPT on Nasdaq
All Insider Reports
All Insider Reports

SHARON BENZENO - trading volume in the past year for Adaptive Biotechnologies Corp

Holdings reported by SHARON BENZENO for Adaptive Biotechnologies Corp

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 296,791 $5,000,928 $16.85 04 Dec 2025 Direct
Stock Option (right to buy) 112,247 04 Dec 2025 Direct Common Stock

Transactions reported by SHARON BENZENO for Adaptive Biotechnologies Corp

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.